Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2007-02-06
2007-02-06
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S613000, C514S614000, C514S616000, C514S617000, C564S123000, C564S148000, C564S150000, C564S153000
Reexamination Certificate
active
10129936
ABSTRACT:
Methods for the treatment of a proliferative disorder are provided in which a subject in need of such treatment is administered an effective amount of a compound selected from: compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein X1and X2are independently H, Cl, F, Br, I, CN, CF3or NO2, and Ar1is a substituted or unsubstituted aryl or a substituted or unsubstituted heteroaryl; and compounds of formula (II) wherein X3and X4are each independently H, Cl, F, Br, I, CN, CF3or NO2; Y is (C2–C6)alkylene or (C2–C6)heteroalkylene; and Z is Cl, F, Br, I, CN, CF3or NO2.
REFERENCES:
patent: 5395934 (1995-03-01), Matyus et al.
patent: 0 665 223 (1995-08-01), None
patent: WO 98/40102 (1998-09-01), None
patent: WO 98/40102 (1998-09-01), None
Parmar et al. ‘Synthesis of substituted benzylidinohydrazines and their monoamine oxidase inhibitory and Anticonvulsant properties,’ Journal of Pharmaceutical Sciences, 1975, Vo. 64, No. 1, pp. 154-157.
Sinha ‘Topoisomerase inhibitors,’ Drugs, 1995, Vo. 49, No. 1, pp. 11-19.
Dancey et al. ‘Current perspective on camptothecins in cancer treatment,’ British Journal of Cancer, 1996, vol. 74, pp. 327-338.
Kim, J. et al., “Alkylation of 4,5-Dichloropyridazan-6-one with α,ω-dibromoalkanes or 4,5-dichloro-1-(ω-bromoalkyl)pyridazin-6-ones” Heterocyclic Chem. 34(1):209-214 (1997).
Parmar, S. et al., “Synthesis of substituted benzylidinohydrazines and their monoamine oxidase inhibitory and anticonvulsant properties” Journal of Pharmaceutical Sciences 64 (1):154-157 (1975).
Santagati, N. et al., “Synthesis and pharmacological study of a series of 3(2H)-pyridazinones as analgesic and anti-inflammatory agents” Ed. Sci. 40 (12):921-929 (1985).
Dunstan Heather
Friend Stephen H.
Lamb John R.
Simon Julian
Fred Hutchinson Cancer Research Center
Townsend and Townsend / and Crew LLP
Wang Shengjun
LandOfFree
Topoisomerase poisons for the treatment of proliferative... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topoisomerase poisons for the treatment of proliferative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topoisomerase poisons for the treatment of proliferative... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3833812